Concepedia

Arvin Ighani

AI

Statistics

Publications

10

Citations

242

H-Index

10

Active since

2017

Affiliations

University of Toronto(Current)

Western University

Women's College Hospital

Health Sciences Centre

Probity Medical Research

Arvin Ighani is an author at University of Toronto specializing in clinical trials, medicine, and dermatology.

ORCID

Top concepts

Publications per year

2017–2019

10

Publications

10

Efficacy and safety of switching to ixekizumab in secukinumab nonresponders with plaque psoriasis: A multicenter retrospective study of interleukin 17A antagonist therapies

Jorge R. Georgakopoulos, Michelle Phung, Arvin Ighani et al. · Journal of the American Academy of Dermatology · 2018 · 52 citations · Full text

, , +12

Drug survival of secukinumab in real-world plaque psoriasis patients: A 52-week, multicenter, retrospective study

Jorge R. Georgakopoulos, Arvin Ighani, Michelle Phung et al. · Journal of the American Academy of Dermatology · 2017 · 45 citations

, , +7

Secukinumab dose optimization in adult psoriasis patients: A retrospective, multicenter case series

Michelle Phung, Jorge R. Georgakopoulos, Arvin Ighani et al. · JAAD Case Reports · 2018 · 22 citations · Full text

Efficacy and Safety of Apremilast Monotherapy for Moderate to Severe Psoriasis: Retrospective Study

Arvin Ighani, Jorge R. Georgakopoulos, Linda Zhou et al. · Journal of Cutaneous Medicine and Surgery · 2018 · 21 citations

Ixekizumab (Interleukin 17A Antagonist): 12-week Efficacy and Safety Outcomes in Real-world Clinical Practice

Jorge R. Georgakopoulos, Michelle Phung, Arvin Ighani et al. · Journal of Cutaneous Medicine and Surgery · 2018 · 20 citations

1–5 of 10